Association of serum RANTES concentrations with established cardiovascular risk markers in middle-aged subjects
- 6 February 2009
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 132 (1), 102-108
- https://doi.org/10.1016/j.ijcard.2007.10.038
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Ccr5 But Not Ccr1 Deficiency Reduces Development of Diet-Induced Atherosclerosis in MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Deficiency in CCR5 but not CCR1 protects against neointima formation in atherosclerosis-prone mice: involvement of IL-10Blood, 2006
- Differential Expression of Chemokines, Risk of Stable Coronary Heart Disease, and Correlation with Established Cardiovascular Risk MarkersArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Chemokines in Children With Heterozygous Familiar HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Chemokine RANTES is upregulated in monocytes from patients with hyperhomocysteinemia1Acta Pharmacologica Sinica, 2005
- Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosisEuropean Heart Journal, 2004
- Antagonism of RANTES Receptors Reduces Atherosclerotic Plaque Formation in MiceCirculation Research, 2004
- Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesisThe Journal of cell biology, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- lnterleukin-8 and Related Chemotactic Cytokines—CXC and CC ChemokinesAdvances in Immunology, 1993